- Home
- ESPR vs OSUR Comparison
ESPR vs OSUR Comparison
Compare ESPR & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- OSUR
- Stock Information
- Founded
- ESPR 2008
- OSUR 2000
- Country
- ESPR United States
- OSUR United States
- Employees
- ESPR N/A
- OSUR N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- OSUR Medical/Dental Instruments
- Sector
- ESPR Health Care
- OSUR Health Care
- Exchange
- ESPR Nasdaq
- OSUR Nasdaq
- Market Cap
- ESPR 305.0M
- OSUR 284.9M
- IPO Year
- ESPR 2013
- OSUR 1986
- Fundamental
- Price
- ESPR $1.50
- OSUR $3.41
- Analyst Decision
- ESPR Buy
- OSUR Hold
- Analyst Count
- ESPR 7
- OSUR 2
- Target Price
- ESPR $6.36
- OSUR $5.50
- AVG Volume (30 Days)
- ESPR 3.5M
- OSUR 1.0M
- Earning Date
- ESPR 03-04-2025
- OSUR 05-07-2025
- Dividend Yield
- ESPR N/A
- OSUR N/A
- EPS Growth
- ESPR N/A
- OSUR N/A
- EPS
- ESPR N/A
- OSUR N/A
- Revenue
- ESPR $332,314,000.00
- OSUR $185,827,000.00
- Revenue This Year
- ESPR $5.51
- OSUR N/A
- Revenue Next Year
- ESPR $1.42
- OSUR $8.41
- P/E Ratio
- ESPR N/A
- OSUR N/A
- Revenue Growth
- ESPR 185.66
- OSUR N/A
- 52 Week Low
- ESPR $1.47
- OSUR $2.69
- 52 Week High
- ESPR $3.94
- OSUR $7.13
- Technical
- Relative Strength Index (RSI)
- ESPR 34.95
- OSUR 44.59
- Support Level
- ESPR $1.57
- OSUR $3.34
- Resistance Level
- ESPR $1.86
- OSUR $3.54
- Average True Range (ATR)
- ESPR 0.13
- OSUR 0.22
- MACD
- ESPR -0.01
- OSUR -0.00
- Stochastic Oscillator
- ESPR 7.69
- OSUR 51.80
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.